The acquisition is expected to be neutral to earnings per share in fiscal year 2020, according to the announcement. Further terms of the deal were not disclosed.
Klue’s operating system uses activity trackers and analytics technology in conjunction with artificial intelligence software to detect when a user is eating a meal and provide real-time insights into eating behaviors. The system is expected to be integrated into Medtronic’s Personalized Closed Loop insulin pump system, which is currently in development and will provide personalized and continuously updating automated insulin delivery to simplify and improve diabetes management.
The Klue acquisition comes one year after Medtronic finalized its purchase of Nutrino Health, which uses AI to automatically analyze nutrition as food is consumed and is also being integrated into the PCL system.
More articles on health IT:
New Orleans health department’s access to data is limited following cyberattack
BCBS Association names winner of Data Innovation Challenge
12 technologies that will define health IT in 2020: report
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
